Table 1.
Shows patient demographics, pre- and postoperative visual acuity, corneal complications, and follow-up duration.
| Case | Age | Gender | VKC Duration (Years) | Initial BCVA | Corneal Complications | Final BCVA | Follow-Up Duration Post-Op (Months) |
||
|---|---|---|---|---|---|---|---|---|---|
| RE | LE | RE | LE | ||||||
| 1 | 7 | M | 4 | 6/15 # | 6/12 | Diffuse epitheliopathy | 6/6 # | 6/7.5 | 77 |
| 2 | 11 | M | 4 | 6/24 * | 6/9 | Shield ulcer | 6/15 * | 6/15 | 70 |
| 3 | 7 | M | 8 | 6/9 * | 6/9 * | Shield ulcer | 6/7.5 * | 6/7.5 * | RE-66 LE-63 |
| 4 | 14 | M | 5 | 6/9 * | 6/12 | Shield ulcer | 6/9.5 * | 6/12 | 59 |
(BCVA: Best Corrected Visual Acuity); # eye that underwent surgical excision of giant papillae with MMC; * eyes that underwent surgical excision of giant papillae with MMC with AMT.